Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new proprietary cultivars in Poland, marking the highest ...

Aurora Cannabis has introduced a new range of cannabis oil products, offering five formulations: Aurora THC 25 (Sativa) and Aurora THC 25 (Indica), both in 30mL bottles, along with Aurora 12.5:12. ...

Aurora's medical-cannabis business is a bright spot for the company. Medical sales increased 9% in the most recent quarter, while the company's recreational sales tumbled 45%.

The global cannabis market stands on the cusp of a remarkable period of growth. Industry projections suggest it could grow from $57 billion in 2023 to $444 billion by 2030. This potential 7.7-fold ...

Last quarter, Aurora Cannabis reported just a 5% increase in its top line, compared to the prior-year period, with sales climbing to CA$67.4 million.

EDMONTON, AB, June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new ...